Letters to the Editor

Cell-free DNA sequencing as a potential screening tool for phase I targeted treatment in refractory/relapse diffuse large B cell lymphoma

Hematology Translational Research Laboratory, UMS AMMICa, INSERM US23 / CNRS UMS 3655, Gustave Roussy, Villejuif, France; INSERM U1170, Gustave Roussy, Villejuif
Hematology Department, Gustave Roussy, Villejuif
Hematology Department, Gustave Roussy, Villejuif, France; DITEP, Gustave Roussy, Villejuif
Department of Biostatistics and Epidemiology, Gustave Roussy, Villejuif, France; INSERM U1018, Gustave Roussy, Villejuif
Hematology Translational Research Laboratory, UMS AMMICa, INSERM US23 / CNRS UMS 3655, Gustave Roussy, Villejuif
Department of Biostatistics and Epidemiology, Gustave Roussy, Villejuif
Hematology Department, Gustave Roussy, Villejuif
Hematology Department, Gustave Roussy, Villejuif
Hematology Department, Gustave Roussy, Villejuif
Hematology Department, Gustave Roussy, Villejuif
Department of Medical Biology and Pathology, Gustave Roussy, Villejuif
Department of Medical Biology and Pathology, Gustave Roussy, Villejuif
DITEP, Gustave Roussy, Villejuif
Hematology Translational Research Laboratory, UMS AMMICa, INSERM US23 / CNRS UMS 3655, Gustave Roussy, Villejuif, France; Plateforme de Recherche Gustave Roussy, Centre de Ressources Biologiques, UMS AMMICa, INSERM US23 / CNRS UMS 3655, Villejuif
Hematology Translational Research Laboratory, UMS AMMICa, INSERM US23 / CNRS UMS 3655, Gustave Roussy, Villejuif, France; INSERM U1170, Gustave Roussy, Villejuif, France; Hematology Department, Gustave Roussy, Villejuif, France; DITEP, Gustave Roussy, Villejuif
INSERM U1170, Gustave Roussy, Villejuif, France; DITEP, Gustave Roussy, Villejuif
Haematologica Early view Mar 24, 2022 https://doi.org/10.3324/haematol.2021.280464